Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Too much epidermal growth factor can cause hair loss.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Certain hair and scalp features can predict the severity of alopecia areata.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Alopecia areata patients often have low vitamin D levels.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.